Award notice, first published as presolicitation
Metformin SA Tablets
36E79725R0051
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2025
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 5 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 11 daysNov 12
Description
As published on SAM.gov with the solicitation of August 7, 2025.
Amendment to Extend Due Date and Time for Offers This amendment is issued to extend the due date and time for receipt of offers submitted in response to solicitation 36E79725R0051 for Metformin Hydrochloride (HCL) 24HR Sustained Action (SA) Tablets from 8/11/2025 to 8/25/2025 at 2:30PM Central Time. All other solicitation terms and conditions remain unchanged. Offerors shall include a completed and signed copy of the amendment with their proposal.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- 36E79726D0002_1.docx13 KB, December 8, 2025
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Avkare LLC
- UEI
- SFPGXE6XPS93
- CAGE
- 4QGW8
- Vendor location
- Pulaski, TN
- Contract
- 36E79726D0002
- Obligated
- $0.00, potential $90,709,478
- Actions
- 3 between October 30, 2025 and August 27, 2026
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for Metformin Hydrochloride (Hcl) 24HR Sustained Action (Sa) Tablets Period Is December 30, 2025 - December 29, 2026 with Four ONE-YEAR Options.
- Match
- solicitation number 36E79725R0051 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
June 23, 2025
Presolicitation
Metformin 24HR SA Tablets PPV
Due July 28, 2025 at 3:30 PM EDT. SAM.gov, notice 96a43f405ab548098150fe1e0ebe7e63
July 9, 2025
Solicitation, originally presolicitation
Metformin 24HR SA Tablets PPV
Due July 28, 2025 at 3:30 PM EDT. SAM.gov, notice 9e7c3fb7ffcf41d0a9463d1ebc6bf921
July 22, 2025
Solicitation
Metformin 24HR SA Tablets PPV
Due August 11, 2025 at 3:30 PM EDT. SAM.gov, notice b14aa0cd46d64a0589c6b5c4c5e46e58
August 7, 2025
Solicitation
Metformin 24HR SA Tablets PPV
Due August 25, 2025 at 3:30 PM EDT. SAM.gov, notice 29a334703414460eb4970408ec9b0ade
December 8, 2025
Award notice
Awarded to Avkare LLC for $90,709,478. SAM.gov, notice 1448e47c79244fa1afa3b2cad1f8b2d7
1 revisions on SAM
- December 8, 2025: publish, award notice
Points of contact
- Youlanda Duggar, Contract SpecialistYoulanda.Duggar@icloud.com708-786-4943